Conclusion Gabapentin toxicity in patients with chronic kidney disease is underrecognized. Patients with chronic kidney disease often receive inappropriately high gabapentin dosage for their kidney function, occasioning overt toxicity; advanced age and comorbidity predispose these patients for toxicity. Pharmacology Gabapentin and pregabalin are commonly used first-line agents for diabetic peripheral neuropathy and other common neuropathies. Pharmacologically, both agents inhibit alpha-2-delta (α2δ) subunit of N-type voltage-gated calcium channels, a key receptor involved in regulating the excitability of neurons. 3 Peripheral nerve injury results in the upregulation of α2δ-1 receptors in In rare instances, gabapentin can cause DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome. This is a severe allergic reaction that can cause damage to major organs, including the liver and kidneys. If you have existing kidney problems, you may need a lower dose of gabapentin. Although gabapentin is well known for its well recieved pharmacokinetics, it is exclusively eliminated renally, and patients with chronic kidney disease are at risk for toxicity. People with chronic kidney disease who take gabapentin should be very aware of this as to not cause further damage to their kidneys. Gabapentin is an anticonvulsant medication commonly used to treat epilepsy and neuropathic pain. Rare cases of liver and kidney damage have been reported with Gabapentin use. Individuals with pre-existing liver or kidney conditions may be at a higher risk. Regular monitoring of liver and kidney function is essential while taking Gabapentin. Does Gabapentin Affect the Liver or Kidneys in Dogs? Gabapentin is primarily processed by the kidneys, which means that in cases of long-term use, especially at high doses, there’s a slight risk of kidney strain or impairment. However, this is rare, and the medication is generally considered safe for most dogs when monitored carefully. Conclusion Gabapentin toxicity in patients with chronic kidney disease is underrecognized. Patients with chronic kidney disease often receive inappropriately high gabapentin dosage for their kidney function, occasioning overt toxicity; advanced age and comorbidity predispose these patients for toxicity. Conclusion: Gabapentin toxicity in patients with chronic kidney disease is underrecognized. Patients with chronic kidney disease often receive inappropriately high gabapentin dosage for their kidney function, occasioning overt toxicity; advanced age and comorbidity predispose these patients for toxicity. Key takeaways Gabapentin is a medication used to treat seizures, postherpetic neuralgia pain associated with shingles, restless leg syndrome, and diabetic neuropathy. For people with normal kidney function, gabapentin is safe and doesn’t cause kidney complications or trigger kidney disease. Here’s a scenario of using gabapentin in chronic kidney disease. A 42 year old African American man with a history of coronary artery disease and decompensated heart failure s/p heart transplant and chronic kidney disease presented to a hospital on 9/29/16 complaining of shortness of breath, dyspnea upon exertion and LE edema. Conclusion Gabapentin toxicity in patients with chronic kidney disease is underrecognized. Patients with chronic kidney disease often receive inappropriately high gabapentin dosage for their kidney function, occasioning overt toxicity; advanced age and comorbidity predispose these patients for toxicity. Gabapentinoids, including gabapentin and pregabalin, are frequently prescribed as opioid alternatives. Given that gabapentinoids are eliminated from the body by the kidney, we sought to determine the risk of serious adverse events in patients with chronic kidney disease who started a gabapentinoid at a higher versus a lower dose. Discussion. Gabapentin is widely used in the management of pain. It is entirely excreted through the renal system so this needs to be considered in any patient becoming acutely ill and developing renal failure. We describe a patient who developed significant deterioration in her conscious level due to iatrogenic gabapentin overdose. Conclusion. Gabapentin is an anticonvulsive that is widely used for a number of indications at present: diabetic neuropathy, neuropathic pain of other causes, epilepsy, etc. Some of its most common side effects include the following: ataxia, nystagmus, drowsiness, headaches, diplopia, fatigue and myoclonic twitches. 1 All of these effects appear quite often in patients with chronic kidney disease Gabapentinoids are opioid substitutes whose elimination by the kidneys is reduced as kidney function declines. To inform their safe prescribing in older adults with chronic kidney disease (CKD), we examined the 30-day risk of serious adverse events according to the prescribed starting dose. From the Guidelines Gabapentin can affect kidney function, particularly in patients with pre-existing kidney problems, and requires dosage adjustments to prevent toxicity and potential kidney damage. According to the most recent study 1, gabapentinoids, such as gabapentin, can cause life-threatening drug accumulation and toxicity in patients with renal impairments. The study highlights the Introduction Gabapentin is an anticonvulsant medication, commonly used to manage neuropathic pain, and it also finds widespread off-label use in treating various pain and sleep disorders. Notably, gabapentin is exclusively excreted through the kidneys, making its dose reduction essential when given to patients with impaired renal function. Gabapentin does not inherently damage kidneys but requires careful consideration when prescribed to individuals with existing renal impairments. Monitoring kidney function regularly while adjusting dosages based on eGFR levels can help mitigate potential risks associated with this medication. Abstract Background: Gabapentinoids (GPs) are frequently prescribed in individuals with chronic kidney disease (CKD); however, their exclusive renal elimination warrants dose adjustments to decrease risk of toxicity. This study evaluated GP prescribing patterns and whether excessive dosing was associated with increased incidence of gabapentinoid-related adverse events (GRAEs). Yes, Gabapentin can potentially cause kidney problems, especially in individuals with pre-existing kidney conditions.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |